Pharma |
Drug development |
CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health |
Dept. of the Army -- USAMRAA |
6/12/2020 |
Pharma, Life Science Research |
Drug development, mechanistic studies |
CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health |
Dept. of the Army -- USAMRAA |
6/12/2020 |
Clinical |
Therapeutic Drug Monitoring (clinical trials) |
CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health |
Dept. of the Army -- USAMRAA |
6/22/2020 |
Clinical |
Therapeutic Drug Monitoring (clinical trials) |
CDMRP Peer Reviewed Medical Research Program Clinical Trial Award |
Dept. of the Army -- USAMRAA |
8/13/2020 |
Life Science Research |
Metabolomics, Proteomics, Lipidomics |
Fundamental Research to Counter Weapons of Mass Destruction |
Defense Threat Reduction Agency |
|
Life Science Research |
Metabolomics, Proteomics, Lipidomics |
Biological Technologies |
DARPA |
4/22/2021 |
Food and Environmental |
Environmental Monitoring |
ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement |
Centers for Disease Control - ATSDR |
5/8/2020 |
All |
Drug development, mechanistic studies |
CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health |
Dept. of the Army -- USAMRAA |
6/12/2020 |
Life Science Research, Clinical |
Research and Development |
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) |
National Institutes of Health - NIAID |
4/29/2021 |
Life Science Research, Clinical |
Research and Development |
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) |
National Institutes of Health - NIAID |
4/29/2021 |
Life Science Research |
Research and Development |
NSF is accepting proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. |
NSF - RAPID |
|
Life Science Research, Food & Environmental, Pharma |
ALL |
Fiscal Year (FY) 2021 DoD Research and Education Program for Historically Black Colleges and Universities and Minority-Serving Institutions (HBCU/MI) Equipment/Instrumentation. |
Dept of the Army -- Materiel Command |
08/28/2020 |
Forensic |
Ports and Border security |
Combatting COVID-19 Pandemic and Proliferation Threats |
DOS-ISN |
05/29/2020 |
Life Science Research, Food & Environmental, Pharma, Clinical |
ALL |
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) |
HHS-NIH11 |
09/30/2020 |
Food & Environmental |
Hazardous Waste Exposure |
ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement |
HHS-CDC-ATSDR |
06/30/2020 |
Clinical/Life Science Research |
Viral Research |
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence |
National Institutes of Health |
|
Clinical/Life Science Research |
Viral Research |
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) |
National Institutes of Health |
07/22/2020 |
Clinical/Life Science Research |
Viral Research |
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) |
National Institutes of Health |
07/22/2020 |
Environmental/Industrial |
Viral Research |
ATSDR's Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement |
Centers for Disease Control - ATSDR |
06/30/2020 |
Life Science Research, Clinical Research |
Mechanistic Studies |
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
12/16/2020 |
Life Science Research, Clinical Research, Clinical Dianostics |
All |
SARS-CoV-2 (COVID-19) Program Activities |
Office of the Assistant Secretary for Health |
|
All |
Academia |
FY2021 VANNEVAR BUSH FACULTY FELLOWSHIP |
Office of Naval Research |
01/15/2021 |